Edition:
United States

Patient Home Monitoring Corp (PHM.V)

PHM.V on TSX Venture Exchange

0.44CAD
26 Jul 2017
Change (% chg)

-- (--)
Prev Close
$0.44
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,239,699
52-wk High
$0.52
52-wk Low
$0.13

Latest Key Developments (Source: Significant Developments)

Patient Home Monitoring sees Q3 2017 revenue about C$32.5 mln to C$33.5 mln
Wednesday, 24 May 2017 08:00am EDT 

May 24 (Reuters) - Patient Home Monitoring Corp : :Patient Home Monitoring releases second quarter financials; posts increase in quarterly revenues, gross profit and adjusted EBITDA, reports positive net profit for the quarter.Q2 revenue C$31.84 million.Sees Q3 2017 revenue about C$32.5 million to C$33.5 million.Patient Home Monitoring Corp says expecting to generate a consolidated adjusted EBITDA margin percentage of approximately 20-23pct in Q3.  Full Article

Patient Home Monitoring names Steve Lazarus its CFO
Wednesday, 29 Jun 2016 09:48am EDT 

Patient Home Monitoring Corp : Appointed Steve Lazarus to position of chief financial officer . Lazarus' appointment comes as board of directors have taken steps to reduce overhead and realign staff .Patient home monitoring announces appointment of new chief financial officer; overhead reduction and staff realignment; updates regulatory bar requirement.  Full Article

Patient Home Monitoring reports Q2 revenue $33.8 mln vs $13 mln
Thursday, 26 May 2016 09:00am EDT 

Patient Home Monitoring Corp : Posts second quarter financials; announces integration and reimbursement cut restructuring plan on target .Revenues for three months ended March 31, 2016 totaled $33,755,000, as compared to $13,036,000 in same quarter a year ago.  Full Article

Patient Home Monitoring Corp executes definitive purchase agreement to acquire Patient-aids inc. of Ohio
Wednesday, 2 Sep 2015 09:00am EDT 

Patient Home Monitoring Corp :Executes definitive purchase agreement to acquire Patient-aids inc. of Ohio; increase of $17 million in annualized revenue.Acquisition is expected to increase phm's revenues by more than 10%, as well as increase phm's overall EBITDA margins.Says acquisition is accretive and is expected to have an immediate and positive impact on earnings per share.Says will acquire all stock of Patient aids, inc. for about $32 million and 2.7 million phm common shares.  Full Article